• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活方式因素、良性前列腺增生和下尿路症状。

Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms.

机构信息

UCSD Division of Urology, San Diego, CA 92103-8897, USA.

出版信息

Curr Opin Urol. 2011 Jan;21(1):1-4. doi: 10.1097/MOU.0b013e32834100c9.

DOI:10.1097/MOU.0b013e32834100c9
PMID:21045705
Abstract

PURPOSE OF REVIEW

Although age, genetics, and sex steroid hormones play prominent roles in the cause of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), recent epidemiological studies suggest that modifiable lifestyle factors also contribute substantially to the pathogenesis of these conditions.

RECENT FINDINGS

Lifestyle and metabolic factors associated with significantly increased risks of benign prostatic hyperplasia and lower urinary tract symptoms include obesity, diabetes, and meat and fat consumption. Factors associated with decreased risks include physical activity, moderate alcohol intake, and vegetable consumption. Factors for which no clear risk patterns have emerged include lipids and smoking. Randomized clinical trials of lifestyle alterations - such as weight loss, exercise, and diet - for the prevention or treatment of benign prostatic hyperplasia and lower urinary tract symptoms have yet to be performed.

SUMMARY

Lifestyle factors present a novel opportunity for the prevention and treatment of benign prostatic hyperplasia and lower urinary tract symptoms. Although clinical trials of lifestyle modifications have not yet been undertaken, promotion of healthy lifestyle alternatives within the context of standard benign prostatic hyperplasia and lower urinary tract symptoms treatment algorithms is potentially beneficial.

摘要

目的综述:虽然年龄、遗传和性激素在良性前列腺增生(BPH)和下尿路症状(LUTS)的发病机制中起着重要作用,但最近的流行病学研究表明,可改变的生活方式因素也对这些疾病的发病机制有重要影响。

最近发现:与良性前列腺增生和下尿路症状风险显著增加相关的生活方式和代谢因素包括肥胖、糖尿病和肉类及脂肪摄入。与风险降低相关的因素包括体力活动、适度饮酒和蔬菜摄入。而对于脂质和吸烟,目前还没有明确的风险模式。针对良性前列腺增生和下尿路症状的生活方式改变(如减肥、锻炼和饮食)的随机临床试验尚未进行。

总结:生活方式因素为良性前列腺增生和下尿路症状的预防和治疗提供了新的机会。虽然尚未进行生活方式改变的临床试验,但在标准的良性前列腺增生和下尿路症状治疗算法的背景下,提倡健康的生活方式替代方案可能是有益的。

相似文献

1
Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms.生活方式因素、良性前列腺增生和下尿路症状。
Curr Opin Urol. 2011 Jan;21(1):1-4. doi: 10.1097/MOU.0b013e32834100c9.
2
Review of exercise and the risk of benign prostatic hyperplasia.运动与良性前列腺增生风险的综述。
Phys Sportsmed. 2009 Dec;37(4):75-83. doi: 10.3810/psm.2009.12.1745.
3
An algorithm for medical management in male lower urinary tract symptoms.男性下尿路症状的医学管理算法。
Curr Opin Urol. 2011 Jan;21(1):5-12. doi: 10.1097/MOU.0b013e32834100ef.
4
Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.良性前列腺增生和下尿路症状的可改变风险因素:老问题的新方法
J Urol. 2007 Aug;178(2):395-401. doi: 10.1016/j.juro.2007.03.103. Epub 2007 Jun 11.
5
Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.性功能障碍与下尿路症状/良性前列腺增生之间关系的最新进展。
Curr Opin Urol. 2006 Jan;16(1):11-9.
6
Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion.下尿路症状/良性前列腺增生(LUTS/BPH)患者疾病进展的风险因素:专家意见的系统分析
Prostate Cancer Prostatic Dis. 2005;8(3):206-9. doi: 10.1038/sj.pcan.4500806.
7
Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: who are the high-risk patients and what are the best treatment options?下尿路症状提示良性前列腺增生:哪些是高危患者,最佳治疗选择是什么?
Curr Opin Urol. 2011 Jan;21(1):42-8. doi: 10.1097/MOU.0b013e32834100b3.
8
Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?糖尿病与良性前列腺增生/下尿路症状——我们了解多少?
J Urol. 2009 Dec;182(6 Suppl):S32-7. doi: 10.1016/j.juro.2009.07.088.
9
Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.基于社区的健康老年男性人群中提示良性前列腺增生的下尿路症状的危险因素:克林彭研究
J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.
10
The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia.血清前列腺特异性抗原在良性前列腺增生男性患者管理中的应用。
Int J Impot Res. 2008 Dec;20 Suppl 3:S19-26. doi: 10.1038/ijir.2008.53.

引用本文的文献

1
Cross-sectional study on the association between serum uric acid levels and the risk of benign prostatic hyperplasia.血清尿酸水平与良性前列腺增生风险之间关联的横断面研究
BMJ Open. 2025 Mar 18;15(3):e092844. doi: 10.1136/bmjopen-2024-092844.
2
Beyond the Comfort Zone: Strenuous Sports as a Preventive Tactic Against Benign Prostatic Hyperplasia.走出舒适区:剧烈运动作为预防良性前列腺增生的一种策略
Am J Mens Health. 2025 Jan-Feb;19(1):15579883241311209. doi: 10.1177/15579883241311209.
3
Association of Benign Prostatic Hyperplasia With Multimorbidity Among Older Adults: Insights From the Longitudinal Ageing Study in India (LASI), First Wave.
印度纵向老龄化研究(LASI)第一波:老年男性良性前列腺增生与多种疾病的关联
Cureus. 2023 Dec 15;15(12):e50608. doi: 10.7759/cureus.50608. eCollection 2023 Dec.
4
Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study.二甲双胍的使用与良性前列腺增生的长期风险:基于人群的队列研究。
BMJ Open. 2020 Dec 22;10(12):e041875. doi: 10.1136/bmjopen-2020-041875.
5
Interactive Effects of Perinatal BPA or DES and Adult Testosterone and Estradiol Exposure on Adult Urethral Obstruction and Bladder, Kidney, and Prostate Pathology in Male Mice.围产期 BPA 或 DES 与成年睾酮和雌二醇暴露对雄性小鼠成年尿道梗阻及膀胱、肾脏和前列腺病理学的交互作用。
Int J Mol Sci. 2020 May 30;21(11):3902. doi: 10.3390/ijms21113902.
6
Effect of fire needle therapy on mild-moderate benign prostatic hyperplasia: Protocol for a randomized controlled pilot trial.火针疗法对轻中度良性前列腺增生的影响:一项随机对照试验方案
Medicine (Baltimore). 2020 May 22;99(21):e20376. doi: 10.1097/MD.0000000000020376.
7
Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.使用他汀类药物与前列腺体积的纵向变化;多沙唑嗪减少前列腺癌事件研究(REDUCE)的结果。
BJU Int. 2020 Feb;125(2):226-233. doi: 10.1111/bju.14905. Epub 2019 Sep 27.
8
Role of CYP17 rs743572 Polymorphism in Benign Prostatic Hyperplasia: A Multivariate Integrated Analysis.CYP17 rs743572基因多态性在良性前列腺增生中的作用:多变量综合分析
Front Physiol. 2019 Jun 21;10:774. doi: 10.3389/fphys.2019.00774. eCollection 2019.
9
Diet-Induced Hyperinsulinemia as a Key Factor in the Etiology of Both Benign Prostatic Hyperplasia and Essential Hypertension?饮食诱导的高胰岛素血症是良性前列腺增生症和原发性高血压病因学中的关键因素吗?
Nutr Metab Insights. 2018 May 8;11:1178638818773072. doi: 10.1177/1178638818773072. eCollection 2018.
10
Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base.男性下尿路症状储尿期症状管理的最佳实践:循证综述
Ther Adv Urol. 2017 Dec 7;10(2):79-92. doi: 10.1177/1756287217742837. eCollection 2018 Feb.